An inquest revealed that Grace Uludag, a 55-year-old grandmother from Gravesend, Kent, died after taking sertraline, a commonly prescribed antidepressant. Her death on November 11 followed a day during which she experienced severe dizziness and shortness of breath, prompting her to consult her GP who advised contacting emergency services. The next day, after falling at home, Uludag suffered a cardiac arrest leading to her death.

The NHS has issued warnings regarding serious side effects associated with sertraline, particularly serotonin syndrome, which can occur when there is an excessive accumulation of serotonin in the body. This warning arrived after a significant study conducted by researchers at King’s College London and the University of Oxford identified potential health risks, including variability in weight, heart rate, and cholesterol levels, related to the use of certain antidepressants. The information sheds light on the necessity for careful monitoring of patients prescribed with these medications.

The implications of Uludag's case underscore the importance of patient awareness and medical vigilance when prescribing SSRIs. Even common medications, like sertraline, can have significant side effects that are not always well understood by patients or caregivers. This tragic event highlights the need for ongoing research and education about the effects and risks of antidepressants, assuring that proper precautions are in place to prevent further incidents of this nature.